Opcon-A

Active Ingredient(s): Naphazoline + Pheniramine
FDA Approved: * June 8, 1994
Pharm Company: * BAUSCH AND LOMB
Category: Allergies, Cough & Cold

* This drug may consist of multiple approval dates, manufacturers, or distributors. If applicable, they would be listed below under "NDC Database Records".



Opcon-A Overview

Naphazoline/pheniramine, sold under the brand name Naphcon-A among others, is a combination eye drop used to help the symptoms of allergic conjunctivitis such as from hay fever.[1] It contains naphazoline and pheniramine.[2] It is used as an eye drop.[2] Use is not recommended for more than three days.[3] Side effects may include allergic reactions, eye pain, and dilated pupils.[4][3] It is unclear...

Read more Opcon-A Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Naphcon-A

Recent Opcon-A Forums:

Be the first to start a discussion about this drug.

Possible Dosages for this and Related Drugs:

Naphazoline + Pheniramine
  • Solution: 0.025% + 0.3%, 0.027% + 0.3%
  • Solution/drops: 0.025% + 0.3%, 0.02675% + 0.315%
Note: Above list includes dosages for all drugs with the same combination of active ingredients.

NDC Database Records for Opcon-A: (3 results)

Sorted by National Drug Code
  • 24208-430 Opcon-a Ophthalmic Solution/ Drops by Bausch & Lomb Incorporated
  • 61786-557 Opcon-a Ophthalmic Solution/ Drops by Remedyrepack Inc.
  • 70518-0475 Opcon-a Ophthalmic Solution/ Drops by Remedyrepack Inc.

Drugs with one or more similar ingredients: (281 results)

Related Opcon-A Topics:

Visine LR Alternative is Opcon-A!
I used Visine LR for over 20 years. Since its discontinuation, I've researched many eye drops and their ingredients.... 6 replies




Note: All times displayed are GMT - 7.

This information has been independently compiled and is for informational purposes only. It is not intended to be a substitute for medical advice from a qualified healthcare professional; nor is it intended to diagnose, treat, cure or prevent any disease. For more details please see the Medical Disclaimer. This page was last updated on 9 August 2020.

We are committed to your privacy.

Copyright © 2005-2020 All Rights Reserved. MedsChat® is a registered trademark of Limelight Innovations L.L.C. 9888 W Belleview Ave #5000, Denver, CO, 80123, USA